Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 1 2Phase 3 1Phase 1/2 1

Status

Completed 3Not yet recruiting 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 87INDUSTRY 7NETWORK 1

Study Type

Interventional 7

Sponsor

Cancer Type

Gastrointestinal 2Dermatologic 2Gynecologic 1Genitourinary 1Breast 1

Conditions

Melanoma 2Carcinoma, Hepatocellular 2Uterine Cervical Dysplasia 1Triple Negative Breast Neoplasms 1Squamous Intraepithelial Lesions 1Prostatic Neoplasms 1Liver Diseases 1

Interventions

pembrolizumab 1033Carboplatin 971Paclitaxel 942Gemcitabine 799Cisplatin 757Docetaxel 698Bevacizumab 637Nivolumab 520Pemetrexed 507Capecitabine 475Cyclophosphamide 473Fluorouracil 425Dexamethasone 410Rituximab 391Oxaliplatin 352Injections 347Trastuzumab 314atezolizumab 312Cetuximab 291Leucovorin 290Irinotecan 271130-nm albumin-bound paclitaxel 257Prednisone 251Ipilimumab 244Doxorubicin 241Lenalidomide 231Fulvestrant 226fludarabine 219durvalumab 211Erlotinib Hydrochloride 196

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
INDUSTRY × Electroporation × Clear all
NCT04972097 2026-06-02

PRESERVE

Angiodynamics, Inc.

Phase NA Completed
121 enrolled 19 charts
Genitourinary

Prostatic Neoplasms

NCT07191548 2025-10-10

LIVERMET-IRE

Angiodynamics, Inc.

Phase NA Not yet recruiting
50 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

NCT07192731 2025-10-10

LIVERHCC-IRE

Angiodynamics, Inc.

Phase NA Not yet recruiting
50 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT03185013 2023-07-27

REVEAL 1

Inovio Pharmaceuticals

Phase 3 Completed
201 enrolled 23 charts
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia

NCT02531425 2023-05-15

TNBC

OncoSec Medical Incorporated

Phase 1 Completed
10 enrolled
Breast

Triple Negative Breast Neoplasms

NCT01045915 2015-09-11

AMEP

Valerio Therapeutics

Phase 1 Terminated
5 enrolled
Dermatologic

Melanoma

NCT01764009 2015-09-11

AIMM

Valerio Therapeutics

Phase 1/2 Withdrawn
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡